Please turn JavaScript on
World Pharma Today icon

World Pharma Today

Want to stay in touch with the latest updates from World Pharma Today? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: World Pharma Today - Magazine for the C-level Pharma Executives

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  2.23 / day

Message History

Informa Markets has announced that CPHI Americas will relocate to Miami in 2027, marking a significant step in the event’s ongoing development as a platform for pharmaceutical innovation, outsourcing and strategic partnerships. Scheduled for May 25-26, 2027, at the Miami Convention Center, the move is intended to improve international accessibility, encourage greater executiv...


Read full story

Sanofi has partnered with cloud data platform company Snowflake to develop an artificial intelligence-driven tool designed to assist the pharmaceutical giant’s field sales representatives in their day-to-day operations. The collaboration aims to give Sanofi’s field agents faster, more efficient access to business-critical data and insights while they are out in the field, red...


Read full story

Contract research, development, and manufacturing organization (CRDMO) Aragen has announced the successful production of the first commercial-scale GMP batches of Daretabart (hu1418K322A), the lead therapeutic candidate of UK-based Renaissance Pharma Limited. The milestone marks a key step forward in the development of a treatment targeting high-risk neuroblastoma (HRNB), an ...


Read full story

Eli Lilly has entered into a multi-program collaboration with Beijing-based Haisco Pharmaceutical Group, committing an upfront payment of $87 million and exposing itself to up to $2.97 billion in potential milestone payments. The total value of the arrangement could climb to $3.05 billion, with additional single-digit tiered royalties tied to future product sales. The agreeme...


Read full story

Aragen, a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has announced the successful technology transfer and commercial-scale GMP manufacturing of the first batches of Daretabart, Renaissance Pharma’s lead therapeutic candidate for high-risk neuroblastoma. The milestone was achieved within just nine months, highlighting the ...


Read full story